The Latest Breaking News from diabetes

Eli Lilly (LLY) saw steady growth in its last reported quarter, driven by sales from its popular diabetes drug Mounjaro. The stock has had an impressive run over the past year. However, will the momentum be sustained following its upcoming earnings release scheduled for tomorrow? Read on.

Type 2 diabetes is related to an increased risk of kidney stones; however, various forms of treatment for this condition may potentially reduce the risk of kidney stones. Read further on Dynamite News:

Mounjaro will come in a four-dose device known as a KwikPen for people with type 2 diabetes or obesity

Tanker Foundation and other organizations can assist the government in early detection and prevention of complications due to uncontrolled hypertension and diabetes.

Good news might be on the horizon for people with diabetes, as a swallowable insulin pill tucked in a piece of chocolate might replace painful insulin shots in the future.

They identified significant trends in the types of cells lost due to islet cell loss across age groups and sexes, suggesting that insulin-producing beta cell loss was the primary cause of ICL in the elderly. Read further on Dynamite News:

Researchers have found that the new approach helped lower the blood sugar levels of rats with diabetes.

Researchers have looked into the disappearance of pancreatic islet cells in people who have never suffered pancreatitis. Read further on Dynamite News:

Unpublished figures reveal a doubling of products in short supply over past two years